Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis

被引:99
作者
Ling, BC
Wu, JQ
Miller, SJ
Monk, KR
Shamekh, R
Rizvi, TA
DeCourten-Myers, G
Vogel, KS
DeClue, JE
Ratner, N [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Cell Biol, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Neurobiol, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Coll Med, Dept Anat, Cincinnati, OH 45267 USA
[4] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH 45267 USA
[5] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
[6] NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.ccr.2004.10.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Benign neurofibromas and malignant peripheral nerve sheath tumors are serious complications of neurofibromatosis type 1. The epidermal growth factor receptor is not expressed by normal Schwann cells, yet is overexpressed in subpopulations of Nf1 mutant Schwann cells. We evaluated the role of EGFR in Schwann cell tumorigenesis. Expression of EGFR in transgenic mouse Schwann cells elicited features of neurofibromas: Schwann cell hyperplasia, excess collagen, mast cell accumulation, and progressive dissociation of non-myelin-forming Schwann cells from axons. Mating EGFR transgenic mice to Nf1 hemizygotes did not enhance this phenotype. Genetic reduction of EGFR in Nf1(+/-);p53(+/-) mice that develop sarcomas significantly improved survival. Thus, gain- and loss-of-function experiments support the relevance of EGFR to peripheral nerve tumor formation.
引用
收藏
页码:65 / 75
页数:11
相关论文
共 58 条
[1]   Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis [J].
Badache, A ;
Muja, N ;
De Vries, GH .
ONCOGENE, 1998, 17 (06) :795-800
[2]   Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types [J].
Baselga, J ;
Rischin, D ;
Ranson, M ;
Calvert, H ;
Raymond, E ;
Kieback, DG ;
Kaye, SB ;
Gianni, L ;
Harris, A ;
Bjork, T ;
Averbuch, SD ;
Feyereislova, A ;
Swaisland, H ;
Rojo, F ;
Albanell, J .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4292-4302
[3]   TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES [J].
BRANNAN, CI ;
PERKINS, AS ;
VOGEL, KS ;
RATNER, N ;
NORDLUND, ML ;
REID, SW ;
BUCHBERG, AM ;
JENKINS, NA ;
PARADA, LF ;
COPELAND, NG .
GENES & DEVELOPMENT, 1994, 8 (09) :1019-1029
[4]   SCHWANN-CELL PROLIFERATION IN THE POSTNATAL MOUSE - TIMING AND TOPOGRAPHY [J].
BROWN, MJ ;
ASBURY, AK .
EXPERIMENTAL NEUROLOGY, 1981, 74 (01) :170-186
[5]   Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea [J].
Buzard, GS ;
Enomoto, T ;
Anderson, LM ;
Perantoni, AO ;
Devor, DE ;
Rice, JM .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (12) :653-659
[6]   Identification and characterization of early glial progenitors using a transgenic selection strategy [J].
Chandross, KJ ;
Cohen, RI ;
Paras, P ;
Gravel, M ;
Braun, PE ;
Hudson, LD .
JOURNAL OF NEUROSCIENCE, 1999, 19 (02) :759-774
[7]   Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss [J].
Chen, SZ ;
Rio, C ;
Ji, RR ;
Dikkes, P ;
Coggeshall, RE ;
Woolf, CJ ;
Corfas, G .
NATURE NEUROSCIENCE, 2003, 6 (11) :1186-1193
[8]   Mouse models of tumor development in neurofibromatosis type 1 [J].
Cichowski, K ;
Shih, TS ;
Schmitt, E ;
Santiago, S ;
Reilly, K ;
McLaughlin, ME ;
Bronson, RT ;
Jacks, T .
SCIENCE, 1999, 286 (5447) :2172-2176
[9]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[10]   Epidermal growth factor receptor expression in. neurofibromatosis type 1-related tumors and NF1 animal models [J].
DeClue, JE ;
Heffelfinger, S ;
Benvenuto, G ;
Ling, B ;
Li, SW ;
Rui, W ;
Vass, WC ;
Viskochil, D ;
Ratner, N .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1233-1241